Repair Biotechnologies

About Repair Biotechnologies

Repair Biotechnologies is a biotechnology company focused on developing the Cholesterol Degrading Platform (CDP) therapy to address diseases caused by localized cholesterol accumulation, with a primary emphasis on reversing atherosclerosis. The company highlights its first-in-class approach to rapidly reduce arterial plaque, aiming to mitigate cardiovascular events such as stroke and heart attack. Based in Syracuse, New York, the organization operates in research and development for novel cholesterol degradation therapies and related indications. Through ongoing science and partnerships, Repair Biotechnologies seeks to expand the applicability of CDP to multiple cardiovascular and cholesterol-related conditions.